1. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer
    Tiago Aparecido Silva et al, 2020, Journal of Proteomics CrossRef
  2. Role of maspin in cancer
    Rossana Berardi et al, 2013, Clinical and Translational Medicine CrossRef
  3. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
    Jinbo Chen et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
  4. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer
    Kavita Baghel et al, 2019, Asia-Pacific Journal of Clinical Oncology CrossRef
  5. Maspin and it’s evolving role in tumor progression in systemic malignancies
    Shailendra Kapoor, 2014, Breast Cancer CrossRef
  6. Proteomic research and diagnosis in bladder cancer: state of the art review
    Jorge Luis Wilson Jr. et al, 2021, International braz j urol CrossRef
  7. Biomarkers for bladder cancer aggressiveness
    Maria Frantzi et al, 2012, Current Opinion in Urology CrossRef
  8. Developing proteomic biomarkers for bladder cancer: towards clinical application
    Maria Frantzi et al, 2015, Nature Reviews Urology CrossRef
  9. Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer
    Yu-Hsiang Lin et al, 2019, Cancers CrossRef
  10. ULTRASONOGRAPHIC FINDINGS RELATED TO PROGNOSIS IN CANINE TRANSITIONAL CELL CARCINOMA
    Kiwamu Hanazono et al, 2014, Veterinary Radiology & Ultrasound CrossRef
  11. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
    André P. Nicklas et al, 2018, Advances in Therapy CrossRef
  12. SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway
    Bi-Xia Liu et al, 2024, International Immunopharmacology CrossRef